- Home
- EDSA vs BREA Comparison
EDSA vs BREA Comparison
Compare EDSA & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- BREA
- Stock Information
- Founded
- EDSA 2015
- BREA 2022
- Country
- EDSA Canada
- BREA Ireland
- Employees
- EDSA N/A
- BREA N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- BREA Services-Misc. Amusement & Recreation
- Sector
- EDSA Health Care
- BREA Consumer Discretionary
- Exchange
- EDSA Nasdaq
- BREA Nasdaq
- Market Cap
- EDSA 13.8M
- BREA 13.6M
- IPO Year
- EDSA N/A
- BREA 2023
- Fundamental
- Price
- EDSA $2.05
- BREA $6.88
- Analyst Decision
- EDSA Strong Buy
- BREA
- Analyst Count
- EDSA 2
- BREA 0
- Target Price
- EDSA $13.00
- BREA N/A
- AVG Volume (30 Days)
- EDSA 33.4K
- BREA 18.5K
- Earning Date
- EDSA 08-08-2025
- BREA 01-03-2025
- Dividend Yield
- EDSA N/A
- BREA N/A
- EPS Growth
- EDSA N/A
- BREA N/A
- EPS
- EDSA N/A
- BREA N/A
- Revenue
- EDSA N/A
- BREA $2,988,009.00
- Revenue This Year
- EDSA N/A
- BREA N/A
- Revenue Next Year
- EDSA N/A
- BREA N/A
- P/E Ratio
- EDSA N/A
- BREA N/A
- Revenue Growth
- EDSA N/A
- BREA 151.51
- 52 Week Low
- EDSA $1.55
- BREA $5.00
- 52 Week High
- EDSA $5.59
- BREA $19.50
- Technical
- Relative Strength Index (RSI)
- EDSA 52.89
- BREA 96.66
- Support Level
- EDSA $1.91
- BREA $0.66
- Resistance Level
- EDSA $2.14
- BREA $0.79
- Average True Range (ATR)
- EDSA 0.12
- BREA 0.20
- MACD
- EDSA 0.02
- BREA 0.39
- Stochastic Oscillator
- EDSA 64.52
- BREA 84.50
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
About BREA Brera Holdings PLC
Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.